Page 22 - 南京医科大学自然科学版第1期
P. 22

南京医科大学学报(自然科学版)                                  第41卷第1期
               · 16  ·                    Journal of Nanjing Medical University(Natural Sciences)   2021年1月


             ·基础研究·

              RNA干扰Geminin基因表达对脑胶质瘤恶性生物学行为的影响



              王   燕,田 薇 ,章建国,刘益飞,靳 钦
                            *
              南通大学附属医院病理科,江苏 南通               226001




             [摘    要] 目的:探讨Geminin 基因沉默对人脑胶质瘤细胞恶性生物学行为的影响及可能的发生机制。方法:选取南通大学
              附属医院脑外科 2018—2019 年手术切除的 20 例神经胶质瘤患者的新鲜标本,qRT⁃PCR 结合基因表达谱数据动态分析(gene
              expression profilling interactive analysis,GEPIA)数据库分析胶质瘤组织中Geminin基因的表达;设计有效靶向沉默Geminin基因
              的siRNA序列和阴性对照序列,分别转染胶质瘤细胞U251,作为si⁃Geminin组和si⁃NC组,48 h 后,qRT⁃PCR检测各组中Gemi⁃
              nin mRNA的表达情况;分别采用CCK⁃8法、Transwell实验、Western blot法检测各组细胞的增殖情况、迁移和侵袭能力及Gemi⁃
              nin、HBO1、Cdt1的蛋白表达水平。结果:qRT⁃PCR及GEPIA数据库分析结果显示脑胶质瘤组织中Geminin的表达明显高于瘤
              旁组织;siRNA干扰Geminin基因能显著抑制其在U251细胞中的表达;与control组及si⁃NC组相比,si⁃Geminin 组细胞的增殖能
              力、细胞迁移和细胞侵袭的数量均显著降低,Geminin、HBO1及Cdt1蛋白表达水平显著降低。结论:Geminin在脑胶质瘤中高
              表达,敲除其表达可能通过下调HBO1及Cdt1抑制U251细胞的增殖、迁移和侵袭,Geminin有望成为人脑胶质瘤治疗新的分子
              靶点。
             [关键词] Geminin;胶质瘤;siRNA;HBO1;细胞增殖
             [中图分类号] R739.41                   [文献标志码] A                       [文章编号] 1007⁃4368(2021)01⁃016⁃06
              doi:10.7655/NYDXBNS20210104


              Effects of RNA interference with Geminin gene expression on glioma biological behaviors

                                  *
              WANG Yan,TIAN Wei ,ZHANG Jianguo,LIU Yifei,JIN Qin
              Department of Pathology,Affiliated Hospital of Nantong University,Nantong 226001,China


             [Abstract] Objective:To explore the effects of Geminin gene silencing on the biological behavior of human gliomas and the possible
              mechanism. Methods:Totally 20 pairs of fresh glioma specimens collected from patients who received a surgical resection in the
              Department of Brain Surgery in the Affiliated Hospital of Nantong University from 2018 to 2019 were analyzed by qRT⁃PCR combining
              GEPIA database to study the expression of Geminin gene in glioma tissues. The siRNA sequences that effectively targeted Geminin
              gene and the negative control sequences were designed and transfected into glioma U251 cells using Lipofectamine™ 2000 reagent. The
              two groups were defined as siRNA⁃Geminin group and siRNA⁃NC group,respectively. In 48 h after transfection,qRT⁃PCR was used to
              detect the expressions of Geminin mRNA in each group. Then CCK8 method,Transwell assay,and Western blot were used to detect the
              cell proliferation,migration and invasion ability and the levels of Geminin,HBO1 and Cdt1 protein expression respectively. Results:
              Results of both qRT ⁃ PCR and GEPIA database analyses showed that the expression of Geminin mRNA in glioma tissues was
              significantly higher than that in adjacent tissue. The siRNA interference in Geminin gene could significantly inhibit its expression in
              U251 cells. Compared with siRNA ⁃ NC group,the cell proliferation ability,cell migrationand cell invasion quantity of the siRNA ⁃
              Geminin group were significantly reduced,and the expression levels of Geminin,HBO1,and Cdt1 proteins were significantly lowered.
              Conclusion:Geminin is highly expressed in glioma. Knockdown of Geminin could inhibit the proliferation,migration,and invasion of
              U251 cells,possibly by down⁃regulating HBO1 and Cdt1. Thus,Geminin may be expected to be a new molecular target for the treatment
              of human glioma.
             [Key words] Geminin;glioma;siRNA;HBO1;cell proliferation
                                                                            [J Nanjing Med Univ,2021,41(01):016⁃021]

                                                                                                           [1]
             [基金项目] 南通市市级科技计划项目(MSZ18104)                            胶质瘤是目前最常见的恶性原发性脑肿瘤 ,
              ∗                                                 尽管近年来针对胶质瘤的传统治疗方法取得了一
              通信作者(Corresponding author),E⁃mail:tianweiw@163.com
   17   18   19   20   21   22   23   24   25   26   27